Butterfly Network, Inc. Stock

Equities

BFLY

US1241551027

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2024-06-12 pm EDT 5-day change 1st Jan Change
0.9683 USD +3.69% Intraday chart for Butterfly Network, Inc. +1.24% -10.34%
Sales 2024 * 76.34M Sales 2025 * 90.49M Capitalization 204M
Net income 2024 * -88M Net income 2025 * -88M EV / Sales 2024 * 2.67 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 2.25 x
P/E ratio 2024 *
-2.31 x
P/E ratio 2025 *
-2.33 x
Employees 225
Yield 2024 *
-
Yield 2025 *
-
Free-Float 73.43%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Butterfly Network, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 10:00 AM
Butterfly Network Announces Its First Specialty Product, Iq+ Bladder, in the United States CI
Earnings Flash (BFLY) BUTTERFLY NETWORK Reports Q1 Revenue $17.7M, vs. Street Est of $16.8M MT
Transcript : Butterfly Network, Inc., Q1 2024 Earnings Call, May 01, 2024
Butterfly Network, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Butterfly Network, Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
Butterfly Network, Inc., Clinton Health Access Initiative, and Global Ultrasound Institute Partner to Advance Maternal and Fetal Health in South Africa CI
Transcript : Butterfly Network, Inc. - Analyst/Investor Day
Transcript : Butterfly Network, Inc., Q4 2023 Earnings Call, Feb 28, 2024
Butterfly Network, Inc. Provides Earnings Guidance for the Full Year of Fiscal 2024 CI
Butterfly Network, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (BFLY) BUTTERFLY NETWORK Posts Q4 Revenue $16.5M, vs. Street Est of $15.4M MT
Butterfly Network, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Butterfly Network, Inc. Launches Next-Generation Butterfly iQ3 in the United States CI
Sector Update: Health Care Stocks Mixed Pre-Bell Friday MT
More news
1 day+3.69%
1 week+1.24%
Current month-2.67%
1 month-5.07%
3 months-6.89%
6 months+12.15%
Current year-10.34%
More quotes
1 week
0.87
Extreme 0.87
1.00
1 month
0.87
Extreme 0.87
1.09
Current year
0.67
Extreme 0.6741
1.64
1 year
0.67
Extreme 0.6741
2.71
3 years
0.67
Extreme 0.6741
15.65
5 years
0.67
Extreme 0.6741
29.13
10 years
0.67
Extreme 0.6741
29.13
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 23-04-23
Founder 60 11-01-24
Director of Finance/CFO 49 22-05-01
Members of the board TitleAgeSince
Founder 60 11-01-24
Director/Board Member 65 21-02-11
Director/Board Member 54 21-02-11
More insiders
Date Price Change Volume
24-06-12 0.9683 +3.69% 1,212,236
24-06-11 0.9338 -1.71% 866,769
24-06-10 0.95 +6.04% 1,155,006
24-06-07 0.8959 -5.47% 1,123,432
24-06-06 0.9477 -0.91% 784,021

Delayed Quote Nyse, June 12, 2024 at 04:00 pm EDT

More quotes
Butterfly Network, Inc. is a digital health company. The Company is focused on transforming care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. It has two portable ultrasound devices on the market: second-generation Butterfly iQ+ and third-generation Butterfly iQ3. Butterfly iQ+/iQ3 are both powered by its Ultrasound-on-Chip technology, allowing them to power whole-body imaging on a single handheld probe using digital semiconductor technology. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Within the Butterfly application, users can utilize up to six imaging modes, including B-Mode, Color Doppler, M-Mode, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.9683 USD
Average target price
3.375 USD
Spread / Average Target
+248.55%
Consensus